Bill Sponsor
House Bill 5950
117th Congress(2021-2022)
Improving Patient Access to Care and Treatment Act
Introduced
Introduced
Introduced in House on Nov 12, 2021
Overview
Text
Introduced
Nov 12, 2021
Latest Action
Nov 1, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5950
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Democrat
Pennsylvania
Republican
Nebraska
Republican
New York
Democrat
New York
Republican
Pennsylvania
Democrat
Pennsylvania
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Improving Patient Access to Care and Treatment Act

This bill increases the number of days—from 14 to 60—within which a practitioner must administer certain narcotic drugs (e.g., buprenorphine) to a patient for maintenance or detoxification treatment (i.e., substance use disorder treatment) after receiving the drugs from a pharmacy.

Text (1)
November 12, 2021
Actions (4)
11/01/2022
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
11/15/2021
Referred to the Subcommittee on Health.
11/12/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
11/12/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 7:58:48 PM